Navigation Links
AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation
Date:3/15/2011

SAN FRANCISCO, March 15, 2011 /PRNewswire/ -- AstraZeneca today announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC). The Phase III clinical programme is designed to investigate the safety and efficacy of NKTR-118 as a medicine to relieve opioid induced constipation, a common side effect of prescription opioids when used for chronic pain management.  NKTR-118 is part of the exclusive worldwide license agreement announced on September 21, 2009, between AstraZeneca and Nektar Therapeutics (NASDAQ: NKTR).

The Phase III clinical programme will consist of two 12-week, randomized, placebo-controlled efficacy studies (with approximately 630 randomized patients each) and an open-label, randomized, long-term safety study with a "usual care" comparator arm.  The 12 week efficacy studies will compare response rate among placebo and two different doses of NKTR 118 with primary endpoint at 4 weeks. There is a three month safety extension following one of the two 12 week studies.

The long-term safety study will include patients from the 12-week efficacy studies, as well as new patients not previously enrolled. All patients will be randomly assigned to open-label treatment of either NKTR-118 or physician's choice (usual care) laxative regimen.  Safety assessments will also be collected throughout the trials.

"This is a key milestone for NKTR-118," said Anders Ekblom, Executive Vice President of Global Medicines Development, AstraZeneca. "We will put our knowledge and our effort into studying NKTR-118 as a potential effective new treatment option for Opioid Induced Constipation, which continues to be an area of unmet need in patients needing effective pain treatment."

The first regulatory filings based on the programme are planned for 2013.

NOTES TO EDITORS:About NKTR-
'/>"/>

SOURCE AstraZeneca; Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
4. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
5. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
8. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
9. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
10. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
11. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Radiology information system ... used to store, manipulate, and distribute patient radiological ... tracking and scheduling system, result reporting, and an ... HIS and other databases improves the hospital workflow. ... scheduling, patient list management, radiology department workflow management, ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  Sage ... new generation of equipment for the testing of ... release of the new Luminary™ Profiler, the industry,s ... light-based measurement in a cost-effective, portable unit. ... the specific needs of the cannabis industry, the ...
(Date:12/19/2014)... 2014  RESMED INC. (NYSE: RMD ) today ... year 2015 results on Thursday, January 22, 2015, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2ResMed To Announce Second Quarter 2015 Results 2
... Androgen Deprivation and, Chemotherapy Reduced Size of Formerly Resistant Tumors ... Confirm Bavituximab,s Potential to Enhance Multiple ... Combination Regimens for Cancer Therapy -, ATLANTA, and TUSTIN, ... a clinical stage,biopharmaceutical company developing targeted monoclonal antibodies for the,treatment ...
... to More Effective Antibiotics Against ,Superbugs, BOSTON, ... of Engineering may have discovered the path,toward developing ... have developed resistance to common antibiotics. The,researchers have ... bacteria that opens to door to new avenues ...
Cached Medicine Technology:Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 2Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 3Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease 4Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3
(Date:12/19/2014)... Albuquerque, New Mexico (PRWEB) December 19, 2014 ... pain relief industry is excited to announce a new ... gauss rare earth magnets. These are the strongest neodymium ... therapy necklace. Pain Free Living developed the Superior Magnetics ... magnets. , “Pain Free Living performs magnetic therapy using ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 From November 24, ... teacher training for the year 2014 in its Goa ... this year. Through the Indian winters, from November to March, ... the beautiful beach of Arambol, Goa. The Goa training sessions ... previous intakes of yoga teacher training, the 10th intake is ...
(Date:12/19/2014)... After a 13-year absence from active touring, ... the stage to entertain his many worldwide fans. Trisha ... the successful tour has been steadily expanding since the ... Ticketability.com for a large inventory of Garth ... prices. , Music fans have had a long wait ...
(Date:12/19/2014)... 2014 Consilium Staffing, Your Partner ... Society for Federal Health Professionals annual meeting in ... to military and federal healthcare providers. , ... Small Business Engagement (NVSBE) conference last week in ... a vital solution in addressing our nation’s shortage ...
(Date:12/19/2014)... 2014 (HealthDay News) -- Being in good shape seems to ... They looked at data from more than 57,000 Americans, including ... tests between 1991 and 2009. Those in the poorest ... high blood pressure at the start of the study, compared ... of fitness. Of the more than 8,000 people diagnosed ...
Breaking Medicine News(10 mins):Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Being Fit Keeps Blood Pressure in Check 2
... Sept. 5 Edwards Lifesciences,Corporation (NYSE: EW ... heart valves,today announced that it has received CE ... SAPIEN transcatheter aortic heart valve,technology with the RetroFlex ... heart valve is implanted via a,minimally-invasive procedure, without ...
... ALEXANDRIA, Va., Sept. 5 Traditional Latin,American foods have ... these foods that have brought families together for generations ... health. Oftentimes Latin foods are prepared with high-calorie ... According to the American Diabetes,Association (ADA), eating foods high ...
... Inc. (NYSE: WPI ), a leading specialty pharmaceutical,company, ... Food and Drug,Administration (FDA) product approval at its Goa, ... to seek FDA approval to,manufacture additional solid dosage products ... expected to be producing over 1 billion tablets,and capsules ...
... Stahl Cowen Crowley LLC, of Chicago,IL, counsel to ... that Dana Corporation, Inc. has entered into a settlement,agreement ... to,benefits. Dana had sought Bankruptcy Court approval to terminate ... result of the settlement Stahl,Cowen Crowley negotiated on behalf ...
... Brings Over 20 Years Of Experience ... in Sales, Marketing And Operational Excellence, LENEXA, Kan., ... ) announced the appointment of Thomas Kelly,Mann as chief ... than 20 years with 3M,s healthcare information technology,division where ...
... PICK: Immunosuppressive drugs are a double-edged sword to type ... caused when immune cells attack and destroy the insulin ... changed the life of type I diabetics, they neither ... was hoped that islet transplantation would provide a cure, ...
Cached Medicine News:Health News:Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve 2Health News:Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve 3Health News:Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve 4Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility 2Health News:Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee 2Health News:Mediware Names Thomas K. Mann Chief Executive Officer 2Health News:JCI table of contents: Sept. 4, 2007 2Health News:JCI table of contents: Sept. 4, 2007 3Health News:JCI table of contents: Sept. 4, 2007 4Health News:JCI table of contents: Sept. 4, 2007 5Health News:JCI table of contents: Sept. 4, 2007 6Health News:JCI table of contents: Sept. 4, 2007 7Health News:JCI table of contents: Sept. 4, 2007 8Health News:JCI table of contents: Sept. 4, 2007 9Health News:JCI table of contents: Sept. 4, 2007 10Health News:JCI table of contents: Sept. 4, 2007 11Health News:JCI table of contents: Sept. 4, 2007 12
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
Medicine Products: